Research Analysts Offer Predictions for TBPH Q1 Earnings
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Equities researchers at Zacks Research reduced their Q1 2026 earnings per share estimates for shares of Theravance Biopharma in a research note issued on Wednesday, February 26th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post earnings of ($0.38) per share for the […]
